Clinical Trial Update: OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the clinical effectiveness of teriparatide after prior alendronate or risedronate therapy in postmenopausal osteoporosis; the trial has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis Postmenopausal

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED